REGENXBIO Inc. (RGNX)
NASDAQ: RGNX
· Real-Time Price · USD
9.01
0.47 (5.50%)
At close: May 29, 2025, 3:59 PM
8.79
-2.44%
After-hours: May 29, 2025, 05:55 PM EDT
5.50% (1D)
| Bid | 8.17 |
| Market Cap | 451.94M |
| Revenue (ttm) | 156.72M |
| Net Income (ttm) | -157.69M |
| EPS (ttm) | -3.09 |
| PE Ratio (ttm) | -2.92 |
| Forward PE | -5.66 |
| Analyst | Buy |
| Ask | 10.1 |
| Volume | 865,797 |
| Avg. Volume (20D) | 1,122,791 |
| Open | 8.62 |
| Previous Close | 8.54 |
| Day's Range | 8.51 - 9.28 |
| 52-Week Range | 5.04 - 15.36 |
| Beta | 1.11 |
About RGNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RGNX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RGNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+2.63%
RGNX stock has given up its prior gain. Regenxbio ...
Unlock content with
Pro Subscription
2 weeks ago
+2.63%
Regenxbio shares are trading higher following Q1 financial results and after the company announced FDA acceptance and priority review of BLA for RGX-121.
